Signia Pure Charge&Go MaX vs Starkey Evolv AI

The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.

The Starkey Evolv AI is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #30 of 39 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality scores a solid 3.7/5, which is +0.94 points above the category average—a meaningful advantage for users who frequently stream audio from their phone. Speech in noise performance also stands out at 2.8/5, sitting +0.66 points above the category average, though this remains a mixed absolute score. Speech in quiet is solid at 3.4/5, essentially matching the category average. The Evolv AI does show some limitations in our testing. Own voice comfort scores 2.1/5, falling -0.60 points below the category average, which may affect how natural your own speech sounds. Feedback handling presents a more significant gap: while the 3.5/5 score is solid in absolute terms, it sits -1.22 points below the category average of 4.72/5, meaning competing prescription devices generally perform better in feedback stability tests. Professional fitting makes a meaningful difference with this device. The normalized Initial Score of 3.8/5 improves to 4.2/5 after tuning, a +0.4 point gain primarily driven by improvements in speech clarity metrics. At this premium price point, several competitors like the Phonak Sphere Infinio and Oticon Intent deliver higher overall scores. The Evolv AI is best suited for users who prioritize music streaming quality and speech understanding in noise, and who have access to professional fitting services to optimize performance.